Similar articles for PMID: 26870181

Year	Number of Results
2005	1
2008	2
2009	1
2010	1
2011	4
2012	5
2013	6
2014	8
2015	16
2016	15
2017	11
2018	10
2019	21
2020	13
2021	10
2022	5
2023	3
2024	0

1

De-escalation of radiation dose for human papillomavirus-positive oropharyngeal head and neck squamous cell carcinoma: A case report and preclinical and clinical literature review.

Wu CC, Horowitz DP, Deutsch I, Rahmati R, Schecter JM, Saqi A, Wang TJ. Wu CC, et al. Oncol Lett. 2016 Jan;11(1):141-149. doi: 10.3892/ol.2015.3836. Epub 2015 Oct 27. Oncol Lett. 2016. PMID: 26870181 Free PMC article.

2

TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.

Hajek M, Sewell A, Kaech S, Burtness B, Yarbrough WG, Issaeva N. Hajek M, et al. Cancer. 2017 May 15;123(10):1778-1790. doi: 10.1002/cncr.30570. Epub 2017 Mar 13. Cancer. 2017. PMID: 28295222 Free PMC article.

3

De-Escalation Strategies of (Chemo)Radiation for Head-and-Neck Squamous Cell Cancers-HPV and Beyond.

Rühle A, Grosu AL, Nicolay NH. Rühle A, et al. Cancers (Basel). 2021 May 4;13(9):2204. doi: 10.3390/cancers13092204. Cancers (Basel). 2021. PMID: 34064321 Free PMC article. Review.

4

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML. Fakhry C, et al. J Natl Cancer Inst. 2008 Feb 20;100(4):261-9. doi: 10.1093/jnci/djn011. Epub 2008 Feb 12. J Natl Cancer Inst. 2008. PMID: 18270337 Clinical Trial.

5

Clinico-pathological peculiarities of human papilloma virus driven head and neck squamous cell carcinoma: A comprehensive update.

Devaraja K, Aggarwal S, Verma SS, Gupta SC. Devaraja K, et al. Life Sci. 2020 Mar 15;245:117383. doi: 10.1016/j.lfs.2020.117383. Epub 2020 Jan 30. Life Sci. 2020. PMID: 32007572 Review.

6

Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study.

Chen AM, Felix C, Wang PC, Hsu S, Basehart V, Garst J, Beron P, Wong D, Rosove MH, Rao S, Melanson H, Kim E, Palmer D, Qi L, Kelly K, Steinberg ML, Kupelian PA, Daly ME. Chen AM, et al. Lancet Oncol. 2017 Jun;18(6):803-811. doi: 10.1016/S1470-2045(17)30246-2. Epub 2017 Apr 20. Lancet Oncol. 2017. PMID: 28434660 Free PMC article. Clinical Trial.

7

Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck.

Inohara H, Takenaka Y, Yoshii T, Nakahara S, Yamamoto Y, Tomiyama Y, Seo Y, Isohashi F, Suzuki O, Yoshioka Y, Sumida I, Ogawa K. Inohara H, et al. Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):934-41. doi: 10.1016/j.ijrobp.2014.12.032. Int J Radiat Oncol Biol Phys. 2015. PMID: 25832686 Clinical Trial.

8

Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma.

Gabani P, Lin AJ, Barnes J, Oppelt P, Adkins DR, Rich JT, Zevallos JP, Daly MD, Gay HA, Thorstad WL. Gabani P, et al. Radiother Oncol. 2019 May;134:81-88. doi: 10.1016/j.radonc.2019.01.016. Epub 2019 Feb 4. Radiother Oncol. 2019. PMID: 31005228

9

A phase I study afatinib/carboplatin/paclitaxel induction chemotherapy followed by standard chemoradiation in HPV-negative or high-risk HPV-positive locally advanced stage III/IVa/IVb head and neck squamous cell carcinoma.

Chung CH, Rudek MA, Kang H, Marur S, John P, Tsottles N, Bonerigo S, Veasey A, Kiess A, Quon H, Cmelak A, Murphy BA, Gilbert J. Chung CH, et al. Oral Oncol. 2016 Feb;53:54-9. doi: 10.1016/j.oraloncology.2015.11.020. Epub 2015 Dec 17. Oral Oncol. 2016. PMID: 26705063 Free PMC article. Clinical Trial.

10

Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV+ oropharyngeal carcinoma patients: The Quarterback trial.

Misiukiewicz K, Gupta V, Miles BA, Bakst R, Genden E, Selkridge I, Surgeon JT, Rainey H, Camille N, Roy E, Zhang D, Ye F, Jia R, Moshier E, Bonomi M, Hwang M, Som P, Posner MR. Misiukiewicz K, et al. Oral Oncol. 2019 Aug;95:170-177. doi: 10.1016/j.oraloncology.2019.06.021. Epub 2019 Jun 25. Oral Oncol. 2019. PMID: 31345387 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

111 results

Results by year